Although the federal government did not stipulate specific side effects of the liquid, dietary supplement Royal Tongan Limu, it recommended seizure of the product in 2003 due to false health claims that NBTY, Inc. made on its website, reports the U.S. Food and Drug Administration. Instead, NBTY voluntarily destroyed its entire stock of the product. The company also paid a $2 million civil penalty fine for false advertising of Royal Tongan Limu and other products, adds the Federal Trade Commission.
An NBTY subsidiary called Dynamic Essentials, Inc. falsely advertised that Royal Tongan Limu, a seaweed extract, could prevent or treat maladies such as cancer, Alzheimer's disease, diabetes and allergies, explains the Federal Trade Commission. Although the company had no scientific evidence to prove its assertions, it claimed that research studies, tests and scientific opinion backed up its advertising statements. In 2002, the FDA issued a cyber letter warning the company that its fraudulent advertising practices violated the federal Food, Drug and Cosmetic Act, points out Casewatch. After the warning, the company did not immediately cease distributing the product, notes the U.S. Food and Drug Administration.
Rather than submit to seizure, NBTY eventually decided to destroy its inventory of Royal Tongan Limu as well as its relevant literature and other materials, according to the U.S. Food and Drug Administration. In October 2003, it destroyed about 188 tons of the product and related materials worth approximately $2.7 million.